A modified synthesis of iodoazidoaryl prazosin

Journal of Organic Chemistry

Volumn 67, Issue 23, 2002, Pages 8284-8286

  Andrus, Merritt B ^a   Mettath, Sashikumar N ^a   Song, Chun ^a  

^a Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE (MDR);

ADDITION REACTIONS; AMINES; PROTEINS; SUBSTITUTION REACTIONS;

SYNTHESIS (CHEMICAL);

ANTIHYPERTENSIVE AGENT; GLYCOPROTEIN P; IMIDAZOLE DERIVATIVE; IODINE 125; IODOAZIDOPRAZOSIN; LIGAND; PALLADIUM; PIPERAZINE DERIVATIVE; PRAZOSIN; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; AZIDE; AZIDOPRAZOSIN; DRUG DERIVATIVE; PIPERAZINE;

ARTICLE; CATALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; MULTIDRUG RESISTANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; DRUG ANTAGONISM; SYNTHESIS;

ANTIHYPERTENSIVE AGENTS; AZIDES; DRUG RESISTANCE, MULTIPLE; P-GLYCOPROTEIN; PIPERAZINES; PRAZOSIN;

EID: 0037111715     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo026217o     Document Type: Article

References (40)

1. Schinkel, A. H.; Borst, P. Semin. Cancer Biol. 1991, 2, 213-226.
2. Ambudkar, S. V.; Dey, S.; Hrycyna, C. A.; Ramachandra, M.; Pastan, I.; Gottesman, M. M. Annu. Rev. Pharmacol. Toxicol. 1999, 39, 361-373.
3. (a) Horio, M.; Gottesman, M. M.; Pastan, I. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 3580-3584.
4. (b) Chen, C.-J.; Chin, J. E.; Ueda, K.; Clark, D. P.; Pastan, I.; Gotessman, M. M.; Roninson, I. B. Cell 1986, 47, 381-389.
5. (a) Ramachandra, M.; Ambudkar, S. V.; Chen, D.; Hrycyna, C. A.; Dey, S.; Gottesman, M. M.; Pastan, I. Biochemistry 1998, 37, 5010-5016.
6. (b) Dey, S.; Ramachandra, M.; Pastan, I.; Gottesman, M. M.; Ambudkar, S. V. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 10594-10598.
7. (c) Sauna, Z. E.; Ambudkar, S. V. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 2515-2521.
8. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1981, 41, 1967-1972.
9. Pearce, H. L.; Safa, A. R.; Bach, N. J.; Winter, M. A.; Cirtain, M. C.; Beck, W. Y. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 5128-5132.
10. Tsuruo, T.; Iida, H.; Kitatani, Y.; Yokota, K.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1984, 44, 4303-4307.
11. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1983, 43, 2267-2272.
12. (a) Andrus, M. B.; Turner, T. M.; Asgari, D.; Li, W. K. J. Org. Chem. 1999, 64, 2978-2979.
13. (b) Andrus, M. B.; Turner, T. M.; Updegraff, E. P.; Sauna, Z. E.; Ambudkar, S. V. Tetrahedron Lett. 2001, 42, 3819-3822.
14. (c) Andrus, M. B.; Turner, T. M.; Sauna, Z. E.; Ambudkar, S. V. J. Org. Chem. 2000, 65, 4973-4983.
15. (d) Andrus, M. B.; Lepore, S. D.; Turner, T. M. J. Am. Chem. Soc. 1997, 119, 12159-12169.
16. Chauffert, B.; Martin, M.; Hamman, A.; Michel, M. F. Cancer Res. 1986, 46, 825-830.
17. Chiba, P.; Ecker, G.; Jager, W.; Freudhofmayer, E.; Gekeler, V.; Fleischhacker, W. Proc. Am. Cancer Res. 1993, 34, 321.
18. Ford, J. M.; Prozialeck, W. C.; Hait, W. N. Mol. Pharmacol. 1989, 35, 105-115.
19. Ford, J. M.; Bruggemann, E. P.; Pastan, I.; Gottesman, M. M.; Hait, W. N. Cancer Res. 1990, 50, 1748-1756.
20. Twentyman, P. R. Biochem. Pharmacol. 1992, 43, 109-117.
21. Stratmann, K.; Burgoyne, D. L.; Moore, R. E.; Patterson, G. M. L. J. Org. Chem. 1994, 59, 7219-7226.
22. Gaveriaux, C.; Boesch, D.; Jachez, B.; Bollinger, P.; Payne, T.; Loor, F. J. Cell Pharmacol. 1991, 2, 225-234.
23. Sparreboom, A.; Planting, A. S.; Jewell, R. C.; van der Burg, M. E.; van der Gaast, A.; de Brujin, P.; Loos, W. J.; Nooter, K.; Chandler, L. H.; Paul, E. M.; Wissel, P. S.; Verweij, J. Anticancer Drugs 1999, 10, 719-728.
24. Slapak, C. A.; Dahlheimer, J.; Piwnica-Worms, D. J. Clin. Pharamcol. 2001, 41, 29S-38S.
25. Germann, U. A.; Shlyakhter, D.; Mason, V. S.; Zelle, R. E.; Duffy, J. P.; Galullo, V.; Armistead, D. M.; Saunders, J. O.; Boger, J.; Harding, M. W. Anticancer Drugs 1997, 8, 125-140.
26. (a) Greenberger, L. M.; Lisanti, C. J.; Silva, J. T.; Horwitz, S. B. J. Biol. Chem., 1991, 266, 20744-20751.
27. (b) Morris, D. I.; Greenburger, L. M.; Bruggemann, E. P.; Cardarelli, C. O.; Gottesman, M. M.; Pasatn, I.; Seamon, K. B. Mol. Pharmacol. 1994, 46, 329-337.
28. Chang, G.; Roth, C. B. Science 2001, 293, 1793-1800.
29. Dey, S.; Ramachandra, M.; Pastan, I.; Gottesman, M. M.; Ambudkar, S. V. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 10594-10599.
30. (a) Siedman, C. E.; Hess, H.; Homcey, C. J.; Graham, R. M. Biochemistry 1984, 23, 3765-3770.
31. (b) Althuis, T. H.; Hess, H.-J. J. Med. Chem. 1977, 20, 146-149.
32. De Los Angeles, J. E.; Nikulin, V. I.; Shams, G.; Konkar, A. A.; Mehta, R.; Feller, D. R.; Miller, D. D. J. Med. Chem. 1996, 39, 3701-3711.
33. Hirschfeld, J. H.; Buschauer, A.; Elz, S.; Schunack, W.; Ruat, M.; Traiffort, E.; Schwartz, J. J. Med. Chem. 1992, 35, 2231-2238.
34. (a) Wolfe, J. P.; Wagaw, S.; Marcoux, J. F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805-818.
35. (b) Hartwig, J. F. Pure Appl. Chem. 1999, 71, 1417-1423.
36. Huang, J.; Grasa, G.; Nolan, S. P. Org. Lett. 1999, 1, 1307-1309.
37. (a) Andrus, M. B.; Song, C. Org. Lett. 2001, 3, 3761-3764.
38. (b) Andrus, M. B.; Song, C.; Zhang, J. Org. Lett. 2002, 4, 2079-2082.
39. (a) Nishiyama, M.; Yamamoto, T.; Koie, Y. Tetrahedron Lett. 1998, 39, 617-620.
40. (b) Watanabe, M.; Nishiyama, M.; Yamamoto, T.; Koie, Y. Tetrahedron Lett. 2000, 41, 481-483.